| Factor Information | |
|---|---|
| Data ID | 1756 |
| Factor | Aminocaproic acid(infusions on PCICU admission)--after propensity score matching |
| Description | After propensity score matching, the baseline and perioperative characteristics between the groups became similar, with the exception of age and BSA. |
| Biomarker | NA |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | treatment and prognosis |
| Objective | examine for an association between dexmedetomidine use in the immediate postoperative period and subsequent arrhythmia development after heart surgery |
| p Value | <0.005 |
| Conclusion | After propensity score matching, the baseline and perioperative characteristics between the groups became similar, with the exception of age and BSA. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 25878324 |
| Year | 2015 |
| Title | Association between perioperative dexmedetomidine and arrhythmias after surgery for congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | an ongoing prospective observational study | |
| Region | Nashville, USA | |
| Method | prospective observational study | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | DEX(dexmedetomidine) group(Treatment) | CHD group without DEX(Control) |
| Number | 166 | 128 |
| Age | 782 (175 to 1793) days | 180 (108 to 957) days |
| Gender (Male: Female) | 239:229 | 244:224 |
| Marker Level | 35% (166) | 27% (128) |
